Cargando…

Effects of lapatinib on cell proliferation and apoptosis in NB4 cells

Acute promyelocytic leukemia (APL), characterized by the presence of the promyelocytic leukemia (PML)-retinoic acid α receptor (RARα) fusion protein, responds to treatment with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). However, drug resistance and side effects restrict the applicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lu, Zhong, Liang, Zhao, Yi, Chen, Min, Yao, Shifei, Li, Lianwen, Xiao, Chunlan, Shan, Zhiling, Gan, Liugen, Xu, Ting, Liu, Beizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768102/ https://www.ncbi.nlm.nih.gov/pubmed/29387217 http://dx.doi.org/10.3892/ol.2017.7342

Ejemplares similares

NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK
por: Xiao, Chunlan, et al.
Publicado: (2016)

Effects of LG268 on Cell Proliferation and Apoptosis of NB4 Cells
por: Xu, Ting, et al.
Publicado: (2016)

Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation
por: Chen, Min, et al.
Publicado: (2017)

RAS-Responsive Element-Binding Protein 1 Blocks the Granulocytic Differentiation of Myeloid Leukemia Cells
por: Yao, Juanjuan, et al.
Publicado: (2019)

Shikonin suppresses proliferation and induces apoptosis in human leukemia NB4 cells through modulation of MAPKs and c-Myc
por: Shan, Zhi-Ling, et al.
Publicado: (2017)

NLS-RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway
por: Song, Hao, et al.
Publicado: (2016)

ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1
por: Zhang, Zhonghui, et al.
Publicado: (2022)

Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression
por: Guan, Mingxiu, et al.
Publicado: (2018)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021)

Lithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta
por: Li, Liu, et al.
Publicado: (2015)

Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
por: Huang, Huey-Lan, et al.
Publicado: (2011)

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways
por: Liu, Lin, et al.
Publicado: (2016)

Apoptosis drives cancer cells proliferate and metastasize
por: Wang, Rui-An, et al.
Publicado: (2013)

Oleanolic acid inhibits proliferation and induces apoptosis in NB4 cells by targeting PML/RARα
por: LI, HONGMEI, et al.
Publicado: (2013)

Effects of As(2)O(3) nanoparticles on cell growth and apoptosis of NB4 cells
por: DONG, XIAOYAN, et al.
Publicado: (2015)

PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim
por: Park, Sun Hee, et al.
Publicado: (2015)

GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells
por: Chu, Xuan, et al.
Publicado: (2020)

Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2016)

Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib
por: Strickley, John D., et al.
Publicado: (2018)

RIP1-dependent Apoptosis and Differentiation Regulated by Skp2 and Akt/GSK3β in Acute Myeloid Leukemia
por: Dan, Wenran, et al.
Publicado: (2022)

Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory
por: Wang, Hongxia, et al.
Publicado: (2022)

PML(NLS(-)) Inhibits Cell Apoptosis and Promotes Proliferation in HL-60 Cells
por: Gao, Yuan-Mei, et al.
Publicado: (2013)

Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer
por: Leung, Wing-yin, et al.
Publicado: (2015)

Effect of GINS2 on Proliferation and Apoptosis in Leukemic Cell Line
por: Zhang, Xi, et al.
Publicado: (2013)

Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2017)

CRNDE enhances the expression of MCM5 and proliferation in acute myeloid leukemia KG-1a cells by sponging miR-136-5p
por: Liu, Chen, et al.
Publicado: (2021)

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
por: Gandhi, Mitul D, et al.
Publicado: (2014)

Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
por: Ma, S, et al.
Publicado: (2016)

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
por: Chen, Yu-Jen, et al.
Publicado: (2016)

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
por: Geneste, A., et al.
Publicado: (2020)

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL
por: Eustace, Alex J, et al.
Publicado: (2018)

LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma
por: Li, Zhi-Qiang, et al.
Publicado: (2022)

Therapeutic Mechanism of Lapatinib Combined with Sulforaphane on Gastric Cancer
por: Yi, Huixing, et al.
Publicado: (2021)

Location of NLS-RARα protein in NB4 cell and nude mice
por: Wang, Hui, et al.
Publicado: (2017)

Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
por: Yuan, Ye, et al.
Publicado: (2022)

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells
por: Liu, Lin, et al.
Publicado: (2016)

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
por: Cristofanilli, Massimo, et al.
Publicado: (2012)

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study
por: Xie, Yizhao, et al.
Publicado: (2020)

Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib
por: Gao, Ningning, et al.
Publicado: (2016)

Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
por: Chen, Yu-Jen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mojp1392t48robtrgn6it208p3